Infection Diagnostics Articles & Analysis
9 news found
These rigorously validated antigens are suitable for use in HBV mimetics, standard antigens for ELISA, and Western blotting, and are designed to assist researchers in advancing their understanding of HBV infection and developing novel diagnostic methods or more effective antiviral therapies. ...
Currently, the detection of neuraminidase and neuraminidase inhibitors (NIs) utilizing fluorescent neuraminidase assay is a major strategy in studying biological processes and preventing influenza infection. Creative Diagnostics can measure fluorescent substances released by active influenza neuraminidase enzyme. ...
As a consulting and experimental service provider specializing in virology and microbiology, Creative Diagnostics recently introduced CC50/IC50 Assay service with a high level of assay sensitivity and accuracy. ...
The main cell types of EBV infection are epithelial cells and B cells. Once the initial lytic infection of EBV is controlled, EBV latency persists in an individual’s B cells for the rest of the individual’s life. EBV-specific serological assays, such as ELISA, EIA, IFA, chemiluminescence, and immunoblot, are the easiest methods to test for EBV ...
HiberGene Diagnostics are delighted to be recognised as one of Irelands ‘20 Healthtech innovations to watch in 2022’. ...
While rapid ID instrumentation for blood stream infections is now widely available, clinicians often wait additional 1 to 2 days to receive the AST results required to identify the optimal antibiotic therapy, which the ID result alone does not enable. ...
To address this important gap, NOI and OUH, with the support of RCN, have now committed themselves to develop an AI-designed T-cell diagnostic that monitors the underlying T-cell response to the infection. ...
Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat superbug infections and combat antibiotic resistance, today announced that it has been awarded an additional $9.6 million from the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. ...
Inflammatix, a pioneering molecular diagnostics company delivering precision medicine at the point of care, announced findings from a new study published today in Nature Communications that demonstrate its ability to identify patients with bacterial versus viral infections using a data-driven approach that measures the immune system response. ...